“…Further, we found slowed SQSTM1/p62 accumulation in KO neurons during these treatments ( Figure 4(j, l); Table S1). Interestingly, steady state levels of LC3 were unaffected in cultured KO neurons (Figure 4(j,k)), but also in hippocampal lysates prepared from animals at 1 month (Figure 4(m,n); relative LC3-II:I ratio: WT 1 ± 0.012, KO 0.82 ± 0.13, p = 0.24; relative LC3-II: WT 1 ± 0.077, KO 1 ± 0.22, p = 0.99; relative LC3-I: WT 1 ± 0.089, KO 1.21 ± 0.14, p = 0.29; t-test), in agreement with data recently reported [30]. Further, we found a robust decrease in SQSTM1/p62 in KO animals at 1 month ( Figure 4(o,p); relative SQSTM1/p62 protein: WT 1 ± 0.11, KO 0.59 ± 0.05, p = 0.025; t-test), similar to that reported in ap4b1 null mice [13].…”